Search research articles
Contact Us
Filters
Showing results (201-210 of 238) with videos related to
Page
of 24
Sort By:
American Journal of Hematology
|
February 7, 2013
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study
Derlis E Gonzalez, Hadhami Ben Turkia, Elena A Lukina, et al.
American Journal of Hematology
|
November 2, 2017
Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
Ari Zimran, Nadia Belmatoug, Bruno Bembi, et al.
The American Journal of Medicine
|
July 23, 2002
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry
Neal J Weinreb, Joel Charrow, Hans C Andersson, et al.
International Journal of Molecular Sciences
|
October 27, 2022
A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk
Michal Becker-Cohen, Ari Zimran, Tama Dinur, et al.
Thrombosis and Haemostasis
|
September 10, 2021
Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease
Shoshana Revel-Vilk, Mira Naamad, Dafna Frydman, et al.
Journal of Clinical Medicine
|
April 14, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies
Ari Zimran, Jaco Botha, Richard Eastell, et al.
Molecular Genetics and Metabolism
|
December 28, 2010
Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs
Etty Osher, Aviva Fattal-Valevski, Liora Sagie, et al.
Blood Cells, Molecules & Diseases
|
June 22, 2014
A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase
Gregory M Pastores, Milan Petakov, Pilar Giraldo, et al.
Blood Cells, Molecules & Diseases
|
June 9, 2009
The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)
Ari Zimran, Elizabeth Morris, Eugen Mengel, et al.
Life (Basel, Switzerland)
|
June 26, 2025
Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls
Michal Becker-Cohen, Ari Zimran, Tama Dinur, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 238) with videos related to
Sort By:
Page
of 24
American Journal of Hematology
|
February 7, 2013
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study
Derlis E Gonzalez, Hadhami Ben Turkia, Elena A Lukina, et al.
American Journal of Hematology
|
November 2, 2017
Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
Ari Zimran, Nadia Belmatoug, Bruno Bembi, et al.
The American Journal of Medicine
|
July 23, 2002
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry
Neal J Weinreb, Joel Charrow, Hans C Andersson, et al.
International Journal of Molecular Sciences
|
October 27, 2022
A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk
Michal Becker-Cohen, Ari Zimran, Tama Dinur, et al.
Thrombosis and Haemostasis
|
September 10, 2021
Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease
Shoshana Revel-Vilk, Mira Naamad, Dafna Frydman, et al.
Journal of Clinical Medicine
|
April 14, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies
Ari Zimran, Jaco Botha, Richard Eastell, et al.
Molecular Genetics and Metabolism
|
December 28, 2010
Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs
Etty Osher, Aviva Fattal-Valevski, Liora Sagie, et al.
Blood Cells, Molecules & Diseases
|
June 22, 2014
A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase
Gregory M Pastores, Milan Petakov, Pilar Giraldo, et al.
Blood Cells, Molecules & Diseases
|
June 9, 2009
The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)
Ari Zimran, Elizabeth Morris, Eugen Mengel, et al.
Life (Basel, Switzerland)
|
June 26, 2025
Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls
Michal Becker-Cohen, Ari Zimran, Tama Dinur, et al.
Page
of 24